Jacobio Pharmaceuticals Group Co Ltd
HKEX:1167

Watchlist Manager
Jacobio Pharmaceuticals Group Co Ltd Logo
Jacobio Pharmaceuticals Group Co Ltd
HKEX:1167
Watchlist
Price: 1.25 HKD -3.1% Market Closed
Market Cap: 989.7m HKD
Have any thoughts about
Jacobio Pharmaceuticals Group Co Ltd?
Write Note

Jacobio Pharmaceuticals Group Co Ltd
Other Current Assets

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Jacobio Pharmaceuticals Group Co Ltd
Other Current Assets Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Other Current Assets CAGR 3Y CAGR 5Y CAGR 10Y
Jacobio Pharmaceuticals Group Co Ltd
HKEX:1167
Other Current Assets
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Beigene Ltd
HKEX:6160
Other Current Assets
ÂĄ1.1B
CAGR 3-Years
11%
CAGR 5-Years
15%
CAGR 10-Years
N/A
Innovent Biologics Inc
HKEX:1801
Other Current Assets
ÂĄ552.8m
CAGR 3-Years
-5%
CAGR 5-Years
32%
CAGR 10-Years
N/A
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
SSE:603392
Other Current Assets
ÂĄ74.5m
CAGR 3-Years
18%
CAGR 5-Years
33%
CAGR 10-Years
N/A
Chongqing Zhifei Biological Products Co Ltd
SZSE:300122
Other Current Assets
ÂĄ93.1m
CAGR 3-Years
-22%
CAGR 5-Years
17%
CAGR 10-Years
22%
Imeik Technology Development Co Ltd
SZSE:300896
Other Current Assets
ÂĄ33.5m
CAGR 3-Years
74%
CAGR 5-Years
55%
CAGR 10-Years
N/A
No Stocks Found

Jacobio Pharmaceuticals Group Co Ltd
Glance View

Market Cap
989.7m HKD
Industry
Biotechnology

Jacobio Pharmaceuticals Group Co., Ltd. operates as an investment holding company which engages in research and development of new drugs. The company is headquartered in Beijing, Beijing. The company went IPO on 2020-12-21. The firm is primarily responsible for the independent discovery and development of innovative tumor therapies. The firm's main drug development projects include JAB-3068 and JAB-3312 clinical stage allosteric SHP2 inhibitors. The firm mainly conducts business within the domestic market.

Intrinsic Value
0.85 HKD
Overvaluation 32%
Intrinsic Value
Price

See Also

Back to Top